baber/WOPTO huggingface dataset:
Patent DE-69124379-T2 (DE)
Inventor: WALLER CLIVE GREGORY
IPC: G01N9/18
Filed: 1991-08-23
Granted: 1997-08-21
Abstract: PCT No. PCT/AU91/00386 Sec. 371 Date Feb. 19, 1993 Sec. 102(e) Date Feb. 19, 1993 PCT Filed Aug. 23, 1991 PCT Pub. No. WO92/03718 PCT Pub. Date Mar. 5, 1992.A sensor (1) is provided for sensing the entrainment of a fluid of low specific gravity in a fluid of higher specific gravity, particularly the entrainment of refrigerant gas in refrigerant liquid. The sensor (1) is typically installed into a higher pressure liquid supply line (24) of a refrigeration system (26). The sensor (1) has a differential float (16) including a float member (54) pivoted about a pivot (56) in a chamber (14) coupled to the supply line (24). The float member (54) has a specific gravity greater than the specific gravity of both of the fluids in which it operates. However, the location of the pivot (56) intermediate of the length of the float member (54) gives a net specific gravity for the differential float (16) which is less than the specific gravity of one of the fluids. Hence, the differential float (16) can withstand a high pressure operation, say at 2MPa, and can operate as a float for detecting the presence or absence of the fluid of lower specific gravity in the fluid of high specific gravity. The differential float (16) can also be used as gauge snubber (20) or to replace refrigerant capillary control tubes.
Patent DE-69126281-T2 (DE)
Inventor: STEENBAKKERS PETRUS GERARDUS A
IPC: C12N15/02
Filed: 1991-11-25
Granted: 1997-10-16
Abstract: The invention relates to a novel method for the generation of monoclonal antibodies. The method involves the combination of a clonal expansion of B-lymphocytes followed by or preceded by a selection of B-lymphocytes which produce antibodies with the desired specificity. The selected lymphocytes are immortalized. The invention makes it possible to use any source of B-lymphocytes no matter how small.
Patent DE-69128001-T2 (DE)
Inventor: MITSUTAKE HIDEAKI
IPC: G02B5/28
Filed: 1991-07-25
Granted: 1998-03-05
Abstract: A dichroic mirror for reflecting a beam of a given color includes a substrate and a multilayered film formed on the substrate. The multilayered film is constituted by a first dichroic reflecting layer, an intermediate layer, and a second dichroic reflecting layer sequentially from the beam incident side. The first dichroic reflecting layer has a smaller reflection range of one of two orthogonal polarized components of the beam than the other of the two orthogonal polarized components. The intermediate layer rotates a polarization plane of at least part of a beam of the one component of the beam passing through the first dichroic reflecting layer, and the second dichroic reflecting layer reflects the at least part of the beam whose polarization plane is rotated by the intermediate layer. A projector having the dichroic mirror is also disclosed. <IMAGE>
Patent DE-69208494-T2 (DE)
Inventor: KOMAHA TAKAFUMI
IPC: A61K31/665
Filed: 1992-03-27
Granted: 1996-10-24
Abstract: New compounds, which we have named the "Leustroducsins" have the formula (I): <CHEM> in which R represents a 5-methylhexanoyloxy group, a 6-methyloctanoyloxy group or a 7-methyloctanoyloxy group, and salts thereof, and may be prepared by fermentation using a microorganism of the genus Streptomyces, especially a strain of the species Streptomyces platensis, such as strain SANK 60191 (FERM BP-3288). These compounds may be used for the treatment or prophylaxis of: adverse reactions resulting from cancer chemotherapy or radiotherapy; infections; cancer; cerebral dysfunction; and fungal infections.
Patent DE-69211502-T2 (DE)
Inventor: QUELFETER GUY
IPC: H05K7/18
Filed: 1992-11-24
Granted: 1996-10-10
Abstract: Each of the uprights of this cabinet includes a so-called outer section (20) and a so-called inner section (22) delimiting a hollow inner volume (21) used for passing connections along items of equipment supported by the said uprights, these sections being defined so that the said inner volume has, on the one hand, in the direction of the height and, on the other hand, in the direction of the depth, an opening (18, 17) accessible via the front face, enabling the said connections to be accessed easily along the entire length of their path between the points where they enter and leave this volume. 
<IMAGE>
Patent DE-69218463-T2 (DE)
Inventor: WARDLAW STEPHEN C
IPC: G01N15/04
Filed: 1992-01-02
Granted: 1997-10-23
Abstract: Quantification of blood plasma fibrinogen content is made in a sample of anticoagulated whole blood contained in a sampling tube. The tube is a transparent centrifuge tube which contains a sample constituent layer-elongating float. The blood sample is centrifuged in the tube containing the float, and various cell constituent measurements are made. The centrifuged sample is then heated and recentrifuged to cause the precipitated fibrinogen to layer out on top of the float remote from the buffy coat band in the plasma layer. The thickness of the fibrinogen band is then measured, whereby quantification of the fibrinogen content of the blood sample can be made be a precalibrated instrument. <IMAGE>
Patent DE-69224096-T2 (DE)
Inventor: HAYEK ZAMIR
IPC: A61H31/00
Filed: 1992-03-27
Granted: 1998-09-10
Abstract: A chest covering shell (40) of springy material for fitting over a patient's chest is coupled to an air oscillator. Changes in air pressure in the shell (40) cause ventilation of the patient. The shell (40) is used with a backing pad (58) or back plate which has vertically extending supports (66) for engagement with the sides of the shell (40) so as to support them and prevent their flexing during use. The edge of the shell (40) has a seal (50) which runs continuously around the periphery of the shell (40). The seal (50) can include an inwardly directed flap in order to provide an effective seal when positive pressures are applied under the shell (40). The backing pad (58) can be an evacuatable envelope (62, 64) containing a multitude of small particles. In use the backing pad (58) can first be conformed to the shape of the patient and then made stiff by extracting the air from the envelope (62, 64) through an air outlet (70). <IMAGE>
Patent DE-69302369-T2 (DE)
Inventor: GOODCHILD JOHN
IPC: C07H21/00
Filed: 1993-02-04
Granted: 1996-09-05
Abstract: Methods are disclosed for increasing ribozyme catalytic activity without reducing specificity, which methods comprise contacting an RNA molecule with a ribozyme and a facilitator oligonucleotide. The present invention further provides compositions comprising a ribozyme and an effective amount of a facilitator oligonucleotide. Methods are also disclosed for reducing the concentration of Mg<2+> and Mn<2+> required by a ribozyme to catalytically cleave target RNA.
Patent DE-69309775-T2 (DE)
Inventor: MARCO LESLIE S
IPC: B65B61/08
Filed: 1993-05-19
Granted: 1997-07-31
Abstract: A package (P) of substantially identical containers (12) , such as beverage cans, and a carrier (20) and a method of making it in which the carrier (20) has band segments (32, 34, 36, 38) defining container-receiving apertures (14) and additional apertures (22). The carrier (20) is applied so that the containers (12) are received in the container-receiving apertures (14) and so that the band segments (32, 34, 36, 38) engage cylindrical side walls of the containers (12). Among the band segments, terminal cross segments (36) define opposite ends of the carrier (20) and medial cross segments (38) separate the container-receiving apertures (14) in each longitudinal row. Each medial cross segment (38) is partially severed, for a substantial distance along its transverse mid-line to form a slit (S) extending from one of the opposite edges of the carrier (20), towards one of the additional apertures (22). The carrier (20) has at least one secondary slit (54) extending transversely of the carrier (20) between the transverse mid-line and one of the container-receiving apertures (14). The slit (S) enables the containers (12) to be removed from the package easily. <IMAGE>
Patent DE-69315202-T2 (DE)
Inventor: YOUNG MICHAEL JOHN RADLEY
IPC: A61B8/08
Filed: 1993-02-24
Granted: 1998-04-16
Abstract: The apparatus comprises a piezoelectric vibrator adapted to generate ultrasonic energy which is transmitted through an output section 1 to a plastics head 6. The shape of the head 6 may be varied to suit whichever part of a body on which it is to be used. The material and shape of the head 6 is chosen to allow accurate control of frequency and amplitude of the ultrasonic energy. The preferred ultrasonic frequency is in the range of 20-120 kHz.
Patent DE-69320301-T2 (DE)
Inventor: SCHUMACHER CHARLES ERNEST
IPC: B24C1/04
Filed: 1993-05-27
Granted: 1999-04-08
Abstract: PCT No. PCT/CH93/00138 Sec. 371 Date Jan. 27, 1994 Sec. 102(e) Date Jan. 27, 1994 PCT Filed May 27, 1993 PCT Pub. No. WO92/24277 PCT Pub. Date Sep. 9, 1993.A machining head for a water jet cutting machine as well as an aiming device equipping such head, includes: an interchangeable tip (28) coupled to a feed source (A) of water under pressure, an acceleration nozzle (22) fixed to the casing (2) and connected to the interchangeable tip (28), a cutting pipe (60) receiving a water jet (J) emitted by the nozzle (22), and a pipe carrier (62) maintaining the pipe (60) relative to the casing (2), such head being characterized in that it includes regulating means (120a, 120b, 112, 94a, 94b) which permit regulation of the position of the pipe carrier (62) relative to the casing (2) in order to adjust the orientation of the pipe (60) in a manner coaxial to the jet (J) emitted by the nozzle (22).
Patent DE-69320378-T2 (DE)
Inventor: SAMOUR CARLOS M
IPC: A61K31/17
Filed: 1993-01-13
Granted: 1999-04-29
Abstract: New and improved method for the transdermal administration of agents is provided utilizing iontophoresis in conjunction with a water-insoluble, stratum corneum-lipid modifier. The lipid modifier may be prior to iontophoresis or simultaneously therewith. The lipid modifier may be selected from a wide variety of moieties of the general formula R-X where R is a C5 to C28 alkyl or unsaturated alkyl and X is a member of the following: 1,3-dioxane; 1,3-dioxolane; lactam; morpholine; -COOH; -OH; -COOR'; -C-N(R')2; cyclo ethylene and propylene carbonates; -CONH2; -(CH2-CH2O)nH; <CHEM> acetals, and hemiacetals; and wherein R' is lower alkyl (e.g., C1 to C3) and n is an integer of from 1 to 20. Optionally there may be present a polar, water-soluble chemical compound from the group of alcohols, glycols, lactams, dioxolanes, esters, ureas, morpholine and the like. Compositions and articles useful in the processes of the present invention are also provided.
Patent DE-69320895-T2 (DE)
Inventor: JUNG FREDERIC HENRI
IPC: A61K31/40
Filed: 1993-07-16
Granted: 1999-02-11
Abstract: The present invention relates to carbapenems and provides a compound of the formula (I) <CHEM>  wherein:  R<1> is i-hydroxyethyl, 1-fluoroethyl or hydroxymethyl;  R<2> is hydrogen or C1-4alkyl;  R<3> is hydrogen or C1-4alkyl;  P' is of the formula: <CHEM> and one or two of A,B,C,D,E,F,G and H, are nitrogen and the remainder are CH; and P is bonded to the nitrogen of the linking carbamoyl group by a carbon atom, in either ring, is substituted by the carboxy group on a carbon atom, in either ring, and is optionally further substituted, by up to three substitutents, on a carbon atom, in either ring; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
Patent DE-69402866-T2 (DE)
Inventor: PINEAU DIDIER
IPC: B09B3/00
Filed: 1994-07-06
Granted: 1997-11-27
Abstract: Method of rendering inert, with the aid of a plasma torch (2), and especially an arc plasma torch, solid products, and in particular powder or particulate products, wherein said products are vitrified in an oven (1) using said torch. The method is characterized by operating the torch (2) and maintaining the arc plasma permanently immersed, between the melt bath (23) of products in said oven (1) and the torch (2), in a reaction area (25) between the plasma and the raw products to be treated (26); continuously feeding the oven with raw products to be treated (26); discharging the melt products from the bath (23) as they are formed; cooling by quenching the discharged melt products, and at the same time recovering and treating the gases and fumes from the reaction area. Application in rendering inert solid residues derived from household refuse in particular.
Patent DE-69405385-T2 (DE)
Inventor: LOUKO REIJO
IPC: D04H1/42
Filed: 1994-04-15
Granted: 1998-03-26
Abstract: The invention relates to organic fiber-based products and a method of manufacturing such products. According to the method, the fibrous raw material is milled together with a fire-retardant agent to a desired degree of defibering to the end of producing an at least essentially fire-retardant product. According to the invention, the fibrous raw material is admixed with at least a portion of the amount of the fire-retardant agent to be used, after which the material is milled to a desired degree of defibering using a refiner capable of exerting a milling action. Accordingly, when making a product suited for use as thermal insulation, 1/4 - 1/2 of the fire-retardant material is introduced to the fibrous base material prior to defibering in anhydrous form and 1/2 - 3/4 of the fire-retardant material is introduced to the fibrous base material after defibering in hydrous form. According to the invention, recycled paper can be used in the production of an at least essentially fire-retardant organic fiber-based material in which the anhydrous component incorporated therein swells during moisturizing, binds the fibers to each other and thus achieves a structure free from self-compressive settling.
Patent DE-69417218-T2 (DE)
Inventor: HORWEGE KENNETH
IPC: B32B27/30
Filed: 1994-12-16
Granted: 1999-09-30
Abstract: A two layer flexible article includes a first layer of polyvinyl chloride (PVC) and a second layer of polyester polyurethane which incorporates a texturizing agent. The article preferably is a glove formed by the method of dipping a hand shaped form into a first bath containing a PVC plastisol and a second bath containing a polyester polyurethane emulsion incorporating a texturizing agent and a slip agent. In a finished glove of the present invention the PVC layer forms the outside or patient contacting surface and the polyester polyurethane with the texturizing agent and the slip agent incorporated therein forms the inner user contacting surface. Gloves of the present invention are substantially donnable without the need for donning powders.
Patent DE-69420094-T2 (DE)
Inventor: SUTHERLAND ROBERT
IPC: B65D71/28
Filed: 1994-03-29
Granted: 2000-04-13
Abstract: A carrier having an end panel construction that snaps into place during formation of the carrier and has the ability to follow the contour of adjacent curved or beveled packaged articles. Tabs foldably connected to an end panel flap and adjacent dust flaps cause the flaps to snap into place. The dust flaps are either connected to the side panels by angled fold lines or comprise continuations or extensions of the side panels.
Patent DE-69420347-T2 (DE)
Inventor: GANDINI CARLO
IPC: B21D17/04
Filed: 1994-03-22
Granted: 2000-04-13
Abstract: The invention refers to the technical field for manufacturing flexible apparatuses for oleo-hydropneumatic controls of mechanical members. The technical problem to be resolved consist of manufacturing with a new process, also matter of this invention, a flexible equipement which includes metal end joints obtained by cold pressing metal portions making up its components. The equipment includes a flexible tube (3) with a sleeve (2) on the end (c) obtained from a metal circular disc (18) in association with a revolving nut (7) with linked bushing (8). On the other end (d) of the tube (3) is positioned the connection (9). The manufacturing process concerns respectively the end (c) and (d) connections (1) and (9), particularly the ring nut (6), the nut (7), the bushing (8), the nut (10) and all other components. <IMAGE>
Patent DE-69421620-T2 (DE)
Inventor: OLIFF JAMES
IPC: A47F1/04
Filed: 1994-08-31
Granted: 2000-04-20
Abstract: A package for beverage containers such as cans arranged in two or more axially-stacked tiers includes a carton having interconnected top, bottom and side walls. End closure structure connected to at least some of the walls closes one end of the carton. A dispenser for the containers includes first and second apertures defined in the end closure structure. The first aperture extends from one of the side walls and the bottom wall into the end closure structure, and the second aperture extends from the same side wall and the top wall into the end closure structure. The first and second apertures terminate remote from each other such that a portion of the end closure structure extends between the apertures and is connected to the side wall.
Patent DE-69422760-T2 (DE)
Inventor: BOUSSIGNAC GEORGES
IPC: A61M16/00
Filed: 1994-07-29
Granted: 2000-06-15
Abstract: - Respiratory assistance tube (2), the distal end (3) of which is intended to be introduced into the trachea (4) of a patient and is provided with an inflatable balloon (5) for making a seal between the said respiratory assistance tube and the said trachea, and the proximal end of which is intended to be connected to means (7, 8) for feeding respiratory gas into the lungs of the patient, via the said tube. - According to the invention, the said respiratory assistance tube comprises at least one duct (10) passing through the wall of the said tube (2) and establishing communication (10) between the interior (9) of the said tube and the interior (6) of the said balloon (5), as well as a longitudinal duct (17) emerging in the cavity (6) and connecting the latter to the outside of the patient. <IMAGE>
Patent DE-69426250-T2 (DE)
Inventor: KAYAL JOHN J
IPC: C12M3/04
Filed: 1994-08-24
Granted: 2001-06-13
Abstract: The vessel has a cap (20) with an inverted skirt portion (46) inside the normal outer skirt (40) which forms an annular compartment (50). An orifice (54) in the portion of the inverted skirt portion surrounded by the annular compartment area contains a gas permeable membrane (56). A removable plug (22) can be used to seal the orifice. This consists of a cylindrical base (24), an intermediate flange (26) and a hanger tab (28).
Patent DE-69426529-T2 (DE)
Inventor: LOPEZ CABRERA ANTONIO
IPC: A61K9/00
Filed: 1994-09-07
Granted: 2001-08-09
Abstract: The ophtalmic solution comprises (a) the equivalent to 0.001-0,14 % of Diclofenac itself or an isomer, or a derivative or one of the pharmaceuticaly acceptable salts thereof; (b) the equivalent to a value of 0.001-0.45 % of Tobramicine, obtained from Tobramicine itself or from an isomer or a derivative or one of its pharmaceutically acceptable salts thereof; (c) optionally a solubilizer, an isotonizer, a pH damper, a viscosizer, a chelator, a preserving agent, and/or an excipient for pharmaceutical hydrogels. Application to the treatment of ocular and otic inflammations and/or infections.
Patent DE-69432896-T2 (DE)
Inventor: NORRIS G
IPC: H04R5/027
Filed: 1994-04-01
Granted: 2003-12-24
Abstract: An ear piece device (10) configured for being supported in the ear and providing a microphone (25) which is within a housing (11). A microphone element (28) is coupled within a casing (25). A support gasket (51) formed of acoustical absorbing materials is interposed around the microphone casing (25) and forms a bridge between the housing (11) and the microphone casing (25). A speaker element (13) may be included within the ear device (10) and can be decoupled acoustically so as to avoid feedback. This device (10) can operate with full duplex and enable hands free communication and direct voice command by user through computer modems, telephone networks and other communication systems.
Patent DE-69433647-T2 (DE)
Inventor: SPRECHER A
IPC: C12P21/02
Filed: 1994-11-02
Granted: 2004-08-05
Abstract: The present invention provides isolated DNA molecules comprising a DNA segment encoding novel human Kunitz-type inhibitors. Also provided are DNA constructs comprising a first DNA segment encoding a novel human Kunitz-type inhibitor wherein said first DNA segment is operably linked to additional DNA segments required for the expression for the first DNA segment, as well as host cells containing such DNA constructs and methods for producing proteins from the host cells.
Patent DE-69434911-T2 (DE)
Inventor: SACKLER RICHARD
IPC: A61K45/00
Filed: 1994-11-22
Granted: 2007-08-30
Abstract: Oral sustained release opioid formulation comprises: an opioid analgesic, a retardant material to cause the opioid analgesic to be released at a rate to provide an analgesic effect after oral admin. to a human patient for 24 hrs, the formulation when administered in humans providing an initially rapid rate of rise in the plasma conc. of the opioid characterised by providing an absorption half-life of 1-8 hrs. in the fastened state. Method for titrating human patients with a sustained release oral opioid formulation comprises: 1) administering to a human patient on a once-a-day basis a unit dose of an oral sustained release formulation comprising a dose of an opioid analgesic and a retardant material as described above, 2) monitoring pharmacokinetic and pharmacodynamic parameters elicited by the formulation in the human patient and determining whether the pharmacokinetic and/or pharmacodynamic  parameters are appropriate to treat the patient on a repeated basis, 3) titrating t he patient by adjusting the dose of the opioid analgesic administered to the patient by administering a unit dose of the sustained release opioid analgesic formulation if it is determined that the pharmacokinetic and/or the pharmacodynamic parameters are not satisfactory or maintaining the dose of the opioid analgesic in the unit dose at a previously administered amt. if the pharmacokinetic and/or pharmacodynamic parameters are deemed appropriate, 4) continuing the step 3 titration by adjusting the dose of the opioid analgesic until appropriate steady state pharmacokinetic and/or pharmacodynamic parameters are achieved in the patient, and 5) continuing the admin. of the dose of the opioid analgesic in the oral sustained release formulation on a once-a-day basis until treatment is terminated.
Patent DE-69506869-T2 (DE)
Inventor: EDWARDS NEIL
IPC: H01M8/06
Filed: 1995-06-26
Granted: 1999-06-02
Abstract: PCT No. PCT/GB95/01500 Sec. 371 Date Dec. 23, 1996 Sec. 102(e) Date Dec. 23, 1996 PCT Filed Jun. 26, 1995 PCT Pub. No. WO96/00186 PCT Pub. Date Jan. 4, 1996A self-starting, self-sustaining hydrogen generator comprises a reactor packed with a mass of mixed catalyst, containing supported copper and palladium. A feedstock, of e.g. methanol and an oxygen source such as air, is injected at high velocity into the mass of catalyst through a multipoint entry such as a tube of porous ceramic. The mass of catalyst is preferably configured concentrically around the tube injector, so that the fluid-flow follows a radial path through the reactor. The product gas is high in hydrogen and can be used as a feed for a fuel cell.
Patent DE-69514825-T2 (DE)
Inventor: GRENTHE INGMAR
IPC: C01G53/00
Filed: 1995-11-15
Granted: 2000-10-12
Abstract: There is disclosed a method for preparing a powder containing ammonium salts of W+Co(Ni) complex ions, through chemical reactions, in a water solution at temperatures from 70 DEG  C. to the boiling point and at pH around neutral, between tungstate salts and cobalt (nickel) salts characterized in that said tungstate salts are the highly soluble sodium tungstate or ammonium metatungstate.
Patent DE-69521170-T2 (DE)
Inventor: COTTRELL IAN WILLIAM
IPC: C08B37/00
Filed: 1995-06-07
Granted: 2001-10-04
Abstract: Guar gum which demonstrates greater than 75% light transmission at a wavelength of from about 500-600 nanometers when dispersed in water in the amount of 0.5 parts per 100 parts water and the process for producing such guar gum is disclosed.